Markets › India › NSE › COHANCE

Cohance Lifesciences Ltd

NSE:COHANCEHealthcareNSE:CNX500NSE:CNXSMALLCAP

₹457.70−1.37%At closeAt close · Mon 19 Oct · ≈ AED 17.66 · Market cap $1.86B · Next earnings Mon 2 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	56.7%	56.5%	56.1%	64.7%	68.6%	40.2%	—	—
Operating margin	47.8%	48.0%	47.0%	51.4%	47.2%	10.6%	10.6%	+0.0 pts
Net margin	35.9%	34.4%	30.7%	28.6%	22.4%	7.9%	7.9%	+0.0 pts
EBITDA margin	43.6%	43.9%	42.7%	38.9%	33.9%	19.0%	—	—
Return on equity	30.7%	29.7%	23.7%	14.6%	15.8%	4.6%	4.4%	−0.1 pts
Return on assets	24.6%	24.8%	20.9%	13.3%	8.8%	3.1%	3.1%	+0.0 pts
Return on capital employed	38.5%	39.1%	34.9%	25.2%	21.2%	4.7%	—	—
Debt / equity	0.1×	0.1×	0.0×	0.0×	0.2×	0.1×	0.1×	−3.0%
Debt / assets	9.7%	5.3%	3.6%	2.9%	9.2%	7.0%	—	—
Interest coverage	42.4×	75.1×	49.2×	72.5×	45.8×	6.4×	—	—
Current ratio	2.6×	5.4×	6.4×	11.8×	2.4×	2.8×	2.8×	+0.0%
Quick ratio	1.6×	3.9×	4.3×	9.7×	2.0×	1.9×	—	—
Cash ratio	0.0×	0.2×	0.4×	0.4×	0.2×	0.1×	0.1×	+0.0%
Asset turnover	0.7×	0.7×	0.7×	0.5×	0.4×	0.4×	—	—
Inventory turnover	2.1×	1.9×	1.8×	1.6×	2.3×	2.4×	—	—
Receivables turnover	9.9×	5.6×	7.5×	7.9×	4.2×	3.3×	—	—
Dividend payout	7.0%	22.4%	49.5%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.